Cargando…

SAT-295 Low Dose rFSH Prior to HCG-rFSH Therapy in Kallmann Syndrome

[Background] Kallmann syndrome (KS) is known as a disorder characterized by hypogonadotropic hypogonadism and anosmia. Sato et al. reported that approximately 60% of Congenital male hypogonadotropic hypogonadism (CMHH) could not achieve sufficient spermatogenesis with the current hCG-rFSH combinatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshizawa-Ogasawara, Atsuko, Yanai, Toshihiro, Sato, Naoko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Pediatric Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551952/ http://dx.doi.org/10.1210/js.2019-SAT-295

Ejemplares similares

Comparison between cycles of the same patients when using recombinant luteinizing hormone + recombinant follicle stimulating hormone (rFSH), human menopausal gonadotropin + rFSH and rFSH only
por: Tayyar, Ahter Tanay, et al.
Publicado: (2018)

Addition of low dose hCG to rFSh benefits older women during ovarian stimulation for IVF
por: Gomaa, Hala, et al.
Publicado: (2012)

Effect of rLH Supplementation during Controlled Ovarian Stimulation for IVF: Evidence from a Retrospective Analysis of 1470 Poor/Suboptimal/Normal Responders Receiving Either rFSH plus rLH or rFSH Alone
por: Canosa, Stefano, et al.
Publicado: (2022)

Cost-effectiveness analysis on the use of rFSH + rLH for the treatment of anovulation in hypogonadotropic hypogonadal women
por: Papaleo, Enrico, et al.
Publicado: (2014)

Dose-dependent stimulation of human follicular steroidogenesis by a novel rhCG during ovarian stimulation with fixed rFSH dosing
por: Bøtkjær, Jane Alrø, et al.
Publicado: (2022)

Low dose of rFSH [100 IU] in controlled ovarian hyperstimulation response: a pilot study
por: Barbosa, Caio Parente, et al.
Publicado: (2014)

Required amount of rFSH, HP-hMG and HP-FSH to reach a live birth: a systematic review and meta-analysis
por: Bordewijk, E M, et al.
Publicado: (2019)

Genetic Polymorphisms Influence the Ovarian Response to rFSH Stimulation in Patients Undergoing In Vitro Fertilization Programs with ICSI
por: Boudjenah, Radia, et al.
Publicado: (2012)

Early hCG addition to rFSH for ovarian stimulation in IVF provides better results and the cDNA copies of the hCG receptor may be an indicator of successful stimulation
por: Drakakis, Peter, et al.
Publicado: (2009)

Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol
por: Griesinger, Georg, et al.
Publicado: (2016)

Corifollitropin alfa or rFSH treatment flexibility options for controlled ovarian stimulation: a post hoc analysis of the Engage trial
por: Leader, Arthur, et al.
Publicado: (2013)

Randomized controlled trial comparing embryonic quality in rFSH versus hMG in the IVF protocol with GnRH Antagonist
por: Chapon, Rita de Cassia Borges, et al.
Publicado: (2021)

A Randomized Controlled Trial on the Efficacy and Safety of Low-Dose hCG in a Short Protocol with GnRH Agonist and Ovarian Stimulation with Recombinant FSH (rFSH) During the Follicular Phase in Infertile Women Undergoing ART
por: Siristatidis, Charalampos, et al.
Publicado: (2021)

PIVET rFSH dosing algorithms for individualized controlled ovarian stimulation enables optimized pregnancy productivity rates and avoidance of ovarian hyperstimulation syndrome
por: Yovich, John L, et al.
Publicado: (2016)

Corifollitropin alfa compared to daily rFSH or HP-HMG in GnRH antagonist controlled ovarian stimulation protocol for patients undergoing assisted reproduction
por: Souza, Priscila Morais Galvão, et al.
Publicado: (2017)

A Markov-model simulation of IVF programs for PCOS patients indicates that coupling myo-Inositol with rFSH is cost-effective for the Italian Health System
por: Beresniak, Ariel, et al.
Publicado: (2023)

Comparative economic study of the use of corifollitropin alfa and daily rFSH for controlled ovarian stimulation in older patients: Cost-minimization analysis based on the PURSUE study
por: Barrenetxea, Gorka, et al.
Publicado: (2018)

Comparing clomiphen citrate plus HMG with clomiphen citrate plus rFSH in IUI cycles in couples with unexplained or male factor infertility: A prospective randomized study
por: Azargoon, Azam, et al.
Publicado: (2013)

Human recombinant follicle stimulating hormone (rFSH) compared to urinary human menopausal gonadotropin (HMG) for ovarian stimulation in assisted reproduction: a literature review and cost evaluation
por: Levi Setti, P. E., et al.
Publicado: (2014)

Dose-Exposure Proportionality of a Novel Recombinant Follicle-Stimulating Hormone (rFSH), FE 999049, Derived from a Human Cell Line, with Comparison Between Caucasian and Japanese Women After Subcutaneous Administration
por: Olsson, Håkan, et al.
Publicado: (2015)

Highly Purified Human Menopausal Gonadotropin (HP-hMG) Versus Recombinant Follicle-Stimulating Hormone (rFSH) for Controlled Ovarian Stimulation in US Predicted High-Responder Patients: A Cost-Comparison Analysis
por: Khair, Andrew, et al.
Publicado: (2023)

FSH Beyond Fertility
por: Lizneva, Daria, et al.
Publicado: (2019)

Pharmacogenetics of FSH Action in the Male
por: Schubert, Maria, et al.
Publicado: (2019)

Pharmacogenetics of FSH Action in the Female
por: Conforti, Alessandro, et al.
Publicado: (2019)

Molecular Mechanisms of Action of FSH
por: Casarini, Livio, et al.
Publicado: (2019)

Clinical Use of FSH in Male Infertility
por: Behre, Hermann M.
Publicado: (2019)

Commentary: Molecular Mechanisms of Action of FSH
por: Cannarella, Rossella, et al.
Publicado: (2019)

Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis
por: Santi, Daniele, et al.
Publicado: (2017)

Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis
por: Younis, Johnny S.
Publicado: (2017)

SUN-239 A Case with Elevated Serum Follicle-Stimulating-Hormone (FSH) Concentrations Due to Macro-FSH
por: Hattori, Naoki, et al.
Publicado: (2019)

Response: Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis
por: Santi, Daniele, et al.
Publicado: (2018)

Gain–of–Function Genetic Models to Study FSH Action
por: McDonald, Rosemary, et al.
Publicado: (2019)

Individualization of FSH Doses in Assisted Reproduction: Facts and Fiction
por: Broekmans, Frank J.
Publicado: (2019)

Identification of Smad Response Elements in the Promoter of Goldfish FSHβ Gene and Evidence for Their Mediation of Activin and GnRH Stimulation of FSHβ Expression
por: Lau, Man-Tat, et al.
Publicado: (2012)

FSH Requirements for Follicle Growth During Controlled Ovarian Stimulation
por: Abbara, Ali, et al.
Publicado: (2019)

Controlled ovarian stimulation with r-FSH plus r-LH vs. HMG plus r-FSH in patients candidate for IVF/ICSI cycles: An RCT
por: Shahrokh Tehraninejad, Ensieh, et al.
Publicado: (2017)

Increased maternal hCG concentrations in early in vitro pregnancy with elevated basal FSH
por: Han, Xiao, et al.
Publicado: (2018)

FSH and bone: Comparison between males with central versus primary hypogonadism
por: Giovanelli, Luca, et al.
Publicado: (2022)

SAT-416 IGSF1 Does Not Regulate FSH Synthesis or Secretion
por: Brûlé, Emilie, et al.
Publicado: (2019)

Differential FSH Glycosylation Modulates FSHR Oligomerization and Subsequent cAMP Signaling
por: Agwuegbo, Uchechukwu T., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dgglibfk3vcnbvk9t6oej80la9